PetMed Express Inc (PETS) Files 10-K for the Fiscal Year Ended on March 31, 2017

GuruFocus.com
0

- By insider

PetMed Express Inc (PETS) files its latest 10-K with SEC for the fiscal year ended on March 31, 2017. PetMed Express Inc is a nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs, cats, and horses direct to the consumer. PetMed Express Inc has a market cap of $707.540 million; its shares were traded at around $34.47 with a P/E ratio of 29.67 and P/S ratio of 2.85. The dividend yield of PetMed Express Inc stocks is 2.24%. PetMed Express Inc had annual average EBITDA growth of 4.00% over the past ten years. GuruFocus rated PetMed Express Inc the business predictability rank of 2-star.


For the last quarter PetMed Express Inc reported a revenue of $63.0 million, compared with the revenue of $55.39 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $249.2 million, an increase of 6.2% from last year. For the last five years PetMed Express Inc had an average revenue growth rate of 0.9% a year.

The reported diluted earnings per share was $1.17 for the year, an increase of 14.7% from previous year. Over the last five years PetMed Express Inc had an EPS growth rate of 7% a year. The PetMed Express Inc had a decent operating margin of 15.04%, compared with the operating margin of 13.8% a year before. The 10-year historical median operating margin of PetMed Express Inc is 14.03%. The profitability rank of the company is 7 (out of 10).

At the end of the fiscal year, PetMed Express Inc has the cash and cash equivalents of $58.7 million, compared with $37.6 million in the previous year. The company had no long term debt. PetMed Express Inc has a financial strength rank of 10 (out of 10).

At the current stock price of $34.47, PetMed Express Inc is traded at 84.2% premium to its historical median P/S valuation band of $18.71. The P/S ratio of the stock is 2.85, while the historical median P/S ratio is 1.53. The intrinsic value of the stock is $12.52 a share, according to GuruFocus DCF Calculator. The stock gained 91.02% during the past 12 months.

Directors and Officers Recent Trades:

  • Director Frank J Formica sold 5,000 shares of PETS stock on 05/16/2017 at the average price of $35.32. The price of the stock has decreased by 2.41% since.

  • Director Ronald J Korn sold 3,000 shares of PETS stock on 05/10/2017 at the average price of $31.84. The price of the stock has increased by 8.26% since.

  • Director Gian Fulgoni sold 35,000 shares of PETS stock on 05/10/2017 at the average price of $32.22. The price of the stock has increased by 6.98% since.

  • CHIEF FINANCIAL OFFICER Bruce S Rosenbloom sold 9,000 shares of PETS stock on 05/08/2017 at the average price of $27. The price of the stock has increased by 27.67% since.

  • CHIEF FINANCIAL OFFICER Bruce S Rosenbloom sold 1,500 shares of PETS stock on 05/01/2017 at the average price of $24. The price of the stock has increased by 43.63% since.

For the complete 20-year historical financial data of PETS, click here.

This article first appeared on GuruFocus.


Advertisement

Recommended Stories